Biologic medicine inclusion in 138 national essential medicines lists
Abstract Background Essential medicines lists (EMLs) are intended to reflect the priority health care needs of populations. We hypothesized that biologic disease-modifying antirheumatic drugs (DMARDs) are underrepresented relative to conventional DMARDs in existing national EMLs. We aimed to survey...
Saved in:
Main Authors: | Raphaël Kraus (Author), Rae S. M. Yeung (Author), Nav Persaud (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A comparison of national essential medicines lists in the Americas
by: Liane Steiner, et al.
Published: (2020) -
Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access
by: Muhamad Z. Ally, et al.
Published: (2020) -
Essential medicine list 2011
by: Keshab Mukhopadhyay, et al.
Published: (2014) -
Essential medicine list 2011
by: Keshab Mukhopadhyay, et al.
Published: (2014) -
Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda
by: Ayo-Oley Baldeh, et al.
Published: (2023)